Home About

Pantoprazole sodium

PANTOPRAZOLE SODIUM

Manufacturer: Sun Pharmaceutical Industries Limited

Score: 141.0

Quick Summary

Pantoprazole sodium is a proton pump inhibitor (PPI) used for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions, including Zollinger-Ellison syndrome. The recommended dosage is 40 mg once daily for up to 8 weeks in adults and children 5 years and older. Important safety information includes contraindications for patients with known hypersensitivity to any component of the formulation, warnings for acute interstitial nephritis, Clostridium difficile-associated diarrhea, and bone fracture, as well as potential interactions with other drugs. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.

Key Clinical Findings and Indications

  • Short-term treatment of erosive esophagitis associated with GERD
  • Maintenance of healing of erosive esophagitis
  • Pathological hypersecretory conditions, including Zollinger-Ellison syndrome

Important Safety Information

Warning

Contraindicated in patients with known hypersensitivity to any component of the formulation

Contraindications

  • Known hypersensitivity to any component of the formulation

Adverse Reactions

  • Headache
  • Diarrhea
  • Nausea
  • Abdominal pain
  • Vomiting
  • Flatulence
  • Dizziness
  • Arthralgia

Dosing Recommendations

General Guidance

No dosage adjustment is recommended based on age, but dose adjustments may be necessary for patients with severe renal impairment or hepatic impairment

Short-term treatment of erosive esophagitis associated with GERD

Adult Dose

40 mg once daily for up to 8 weeks

Pediatric Dose

20 mg once daily for up to 8 weeks for children 5-14 years old, 40 mg once daily for up to 8 weeks for children 15-17 years old

Maintenance of healing of erosive esophagitis

Adult Dose

40 mg once daily

Pediatric Dose

Not established

Special Population Considerations

Pregnancy

  • Pantoprazole should be used during pregnancy only if clearly needed

Nursing Mothers

  • Pantoprazole and its metabolites are excreted in human milk, and a decision should be made whether to discontinue nursing or discontinue the drug

Pediatric Use

  • The safety and effectiveness of pantoprazole for short-term treatment of erosive esophagitis associated with GERD have been established in pediatric patients 1 year through 16 years of age

Geriatric Use

  • In short-term US clinical trials, erosive esophagitis healing rates in elderly patients were similar to those found in patients under the age of 65

Similar Drugs

Pantoprazole sodium delayed-release

PANTOPRAZOLE SODIUM DELAYED-RELEASE

Preferred Pharmaceuticals Inc.

Similarity: 91.6%

Pantoprazole sodium delayed-release

PANTOPRAZOLE SODIUM DELAYED-RELEASE

Lifestar Pharma LLC

Similarity: 91.6%

Omeprazole

OMEPRAZOLE

Quallent Pharmaceuticals Health LLC

Similarity: 85.2%

Dexlansoprazole

DEXLANSOPRAZOLE

ENDO USA, Inc.

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

Bryant Ranch Prepack

Similarity: 79.2%

Dexlansoprazole

DEXLANSOPRAZOLE

A-S Medication Solutions

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

TWI PHARMACEUTICALS, INC.

Similarity: 79.2%

Dexlansoprazole

DEXLANSOPRAZOLE

Mylan Pharmaceuticals Inc.

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

A-S Medication Solutions

Similarity: 79.2%

Dexlansoprazole

DEXLANSOPRAZOLE

Bryant Ranch Prepack

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

A-S Medication Solutions

Similarity: 79.2%

Dexlansoprazole

DEXLANSOPRAZOLE

REMEDYREPACK INC.

Similarity: 79.2%

Dexilant

DEXLANSOPRAZOLE

Takeda Pharmaceuticals America, Inc.

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

TWI PHARMACEUTICALS, INC.

Similarity: 79.2%

Dexlansoprazole

DEXLANSOPRAZOLE

Bryant Ranch Prepack

Similarity: 79.2%

Dexlansoprazole delayed release

DEXLANSOPRAZOLE

Golden State Medical Supply, Inc.

Similarity: 79.2%

Dexilant

DEXLANSOPRAZOLE

Cardinal Health 107, LLC

Similarity: 79.2%

Metoclopramide

METOCLOPRAMIDE

A-S Medication Solutions

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Preferred Pharmaceuticals Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Bryant Ranch Prepack

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Bryant Ranch Prepack

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

American Health Packaging

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Mylan Institutional Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Teva Pharmaceuticals USA, Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

NCS HealthCare of KY, LLC dba Vangard Labs

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

REMEDYREPACK INC.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Teva Parenteral Medicines, Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Teva Parenteral Medicines, Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

ANI Pharmaceuticals, Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Bryant Ranch Prepack

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

NuCare Pharmaceuticals,Inc.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

REMEDYREPACK INC.

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Cardinal Health 107, LLC

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

AvKARE

Similarity: 62.2%

Metoclopramide

METOCLOPRAMIDE

Northwind Pharmaceuticals, LLC

Similarity: 62.2%

Dipentum

OLSALAZINE SODIUM

Meda Pharmaceuticals Inc.

Similarity: 60.1%

MOVANTIK

NALOXEGOL OXALATE

Quality Care Products, LLC

Similarity: 60.0%

MOVANTIK

NALOXEGOL OXALATE

Valinor Pharma, LLC

Similarity: 60.0%

MOVANTIK

NALOXEGOL OXALATE

RedHill Biopharma Ltd

Similarity: 60.0%